कृपया अन्य खोज का प्रयास करें
Surrozen, Inc., a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043, a hepatocyte-specific R-spondin mimetic bispecific fusion protein, which is in Phase 1b clinical trial for the treatment of severe liver diseases, including alcohol-associated hepatitis. The company develops SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies. Surrozen, Inc. is based in South San Francisco, California.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Craig C. Parker | 61 | 2018 | CEO, President & Director |
Shao-Lee Lin | 56 | 2021 | Independent Director |
Eric H. Bjerkholt | 63 | 2023 | Independent Director |
Mace L. Rothenberg | 66 | 2021 | Independent Director |
Scott L. Friedman | - | 2022 | Member of Scientific Advisors |
Sarah Gillmor Hymowitz | - | 2022 | Member of Scientific Advisors |
Willard H. Dere | 70 | - | Member of Scientific Advisors |
Wen-Chen Yeh | 60 | 2016 | Member of Scientific Advisory Board |
Bart Williams | - | - | Member of Scientific Advisors |
David J. Woodhouse | 53 | 2020 | Independent Chairman of the Board |
Harold Eliot Varmus | - | - | Member of Scientific Advisors |
Mary Haak-Frendscho | 67 | 2021 | Independent Director |
Timothy W. Kutzkey | 48 | 2016 | Independent Director |
Anna Berkenblit | 54 | 2018 | Independent Director |
Christopher Y. Chai | 57 | 2021 | Independent Director |
Calvin Kuo | - | - | Co-Founder & Member of Scientific Advisor |
K. Christopher Garcia | - | - | Co-Founder & Member of Scientific Advisory Board |
Roeland Nusse | 74 | - | Co-Founder & Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है